ELIQUIS (APIXABAN) — FDA Approval NDA202155 (BRISTOL MYERS SQUIBB)
ELIQUIS (APIXABAN) — FDA Approval NDA202155 (BRISTOL MYERS SQUIBB) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: ELIQUIS; Active ingredients: APIXABAN; Application number: NDA202155.
| Brand name | ELIQUIS |
|---|---|
| Active ingredients | APIXABAN |
| Application number | NDA202155 |
| Sponsor | BRISTOL MYERS SQUIBB |
| Dosage form | TABLET, FOR SUSPENSION |
| Route | ORAL |
| Marketing status | Prescription |
| Products in application | 3 |
| First approval date | 20121228 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →